Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Virtuos
- Development stage
- Unknown
- Lead developer
- Orthofix
- Modality
- Cell Therapies
- Administration
- Implantation
01
Overview
Virtuos is a cellular bone allograft developed by Orthofix for use in spinal fusion procedures, such as those treating degenerative disc disease. It is a Human Cells, Tissues, and Cellular and Tissue-Based Product (HCT/P) that provides a complete solution for bone repair by supplying an osteoconductive matrix, osteoinductive growth factors, and osteogenic live cells. Virtuos is unique in being a lyophilized (shelf-stable) cellular bone allograft, which simplifies storage and handling compared to traditional cryopreserved cellular grafts. It is specifically processed to ensure cell viability while minimizing immunogenicity, aiming to achieve high fusion rates in lumbar and cervical spine surgeries by facilitating the natural bone healing process.
- Brand names
- Virtuos
- Other names
- Virtuos Cellular Bone AllograftVirtuos Lyocell
Beyond the preview
Go deeper on Virtuos.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Virtuos.